Navigation Links
VetStem Biopharma, Proudly Announces a New Long Term Partnership with VCA West Los Angeles in Support of Stem Cell Therapy Training and Clinical Opportunities.
Date:6/2/2015

Poway, CA (PRWEB) June 02, 2015

“Stem Cell Therapy to help dogs suffering from osteoarthritis joint pain is becoming more mainstream, and it is used often as an adjunct to surgery in large specialty and referral hospitals. Too many general practitioners are not yet aware or comfortable enough with the techniques to offer it widely to their clients. This therapy is most often reserved for the last resort cases - when nothing else works - and when the poor pet can barely lift a paw to get around. It is an easy procedure, and if a pet owner is willing to make the financial commitment (between $2,500 and $3,000) it is something that can be offered much earlier and in most general practice settings. We want to help our colleagues get comfortable with the science and the applications, so stem cell therapy doesn’t remain purely a ‘specialty hospital’ recommendation” stated Dr Nicole Buote, Head of Surgery at VCA West Los Angeles.

“We are very proud that an institution like VCA WLA has considered us as the premier partner for such an initiative. We work hard to develop new ways to help improve the quality of healing in pets, and attack insidious diseases like joint degeneration. It is great to be able to count on clinical experts such as Dr Buote and Dr Bruyette, to continuously challenge us, pushing us to develop faster and better, so we can help many pets in need” said Dr Harman, CEO and Chief Science Officer for VetStem.

“We hope to educate hundreds of LA veterinarians on the technique, and offer them local expertise and clinical support for difficult cases through this unique type of partnership with a state of the art veterinary teaching hospital. VCA WLA is developing a unique win / win relationship model with local area veterinarians. We are proud to be a conduit to such development, with our high quality stem cell therapy service offering”, added Dr Nahama, President and Chief Commercial Officer for VetStem.

About VetStem Biopharma
VetStem Biopharma is a veterinarian lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 12 years and 11,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, Vet-Stem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

About VCA West Los Angeles Animal Hospital
Established in 1984, VCA West Los Angeles Animal Hospital is one of the largest veterinary hospitals in the country in addition to being the first specialty and referral hospital in Los Angeles. Serving Los Angeles, San Fernando Valley, Orange and Ventura counties and the surrounding communities, the facility provides 24/7/365 emergency and critical care services and offers a full complement of specialty services in virtually all areas of veterinary medical specialties. Recently relocated to a 42,000 sq. ft. facility, the hospital is equipped with the most advanced technology to ensure optimal care for its patients. The hospital is actively engaged in veterinary medical research through participation in clinical trials and in education and outreach within the veterinary community through its intern and continuing education programs. VCA West Los Angeles Animal Hospital, located at 1900 S. Sepulveda Blvd., Los Angeles, CA 90025, can be reached at (310) 473-2951, http://www.VCAWLASpecialty.com.

Contacts:
Kristi Hauta
Marketing Operations Manager
khauta(at)vet-stem(dot)com
Ph (858) 748-2004 ext 208
12860 Danielson Court, Suite B
Poway, CA 92064
http://www.vetstem.com

David Bruyette, DVM, DACVIM
Medical Director
VCA West Los Angeles Animal Hospital
Ph (310) 473-2951
http://www.VCAWLASpecialty.com.

Read the full story at http://www.prweb.com/releases/2015/05/prweb12741835.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering
2. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
3. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
4. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
5. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
6. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
7. Biotech Equities Technical Analysis - ARIAD Pharma, Novavax, Galena Biopharma, Geron, and Celldex Therapeutics
8. Stock Updates on Biotech Industry - Array BioPharma, Enzon Pharma, Alkermes, Amarin, and Synergy Pharma
9. HealthCare, Technology Briefing: Market Movers for the Week - Technologies-Scan Corp, GNC, Galena Biopharma, Immunomedics, Amarin
10. Todays Technical View: AstraZeneca, GlaxoSmithKline, Keryx Biopharma, and Raptor Pharma
11. Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2018)... ... , ... Diversified Technologies, Inc. (DTI) has installed a PEF (Pulsed ... Technology and Innovation at ASU. Funded by a USDA NIFA SBIR, the purpose of ... and predator control applications. , Algae ponds get up to 50% consumed by predators ...
(Date:11/5/2018)... ... November 05, 2018 , ... USARAD Holdings Inc., ... Healthineers and several healthcare VC firms announces at Distributed Health 2018 conference November ... by purchasing tokens and obtaining its first radiology interpretations, one of the first ...
(Date:11/3/2018)... , ... November 01, 2018 , ... ... Champion Consortium Summit. Dr. Jean Mulinde, Senior Advisor, Division of Clinical Compliance Evaluation, ... monitor safety and ensure data reliability. , What should clinical research industry stakeholders ...
(Date:10/31/2018)... ... 30, 2018 , ... Myoscience, Inc. announced today that it ... Memphis, Tennessee. This study enrolled 125 patients and compares the effect of ... after total knee replacement surgery (TKA). , The Myoscience iovera° system is currently ...
Breaking Biology Technology:
(Date:11/27/2018)... ... 27, 2018 , ... Victrex has designed a new high-performance ... range of usage temperature compared to existing polymers such as PCTFE. At Valve ... 200 for dynamic sealing applications where gases such as LNG* are stored and ...
(Date:11/20/2018)... ... November 19, 2018 , ... Cloudponics , maker of the GroBox ... a discount of $420 for its industry-leading product during the holiday season. , ... with other discount and payment options available on the Cloudponics website . ...
(Date:11/20/2018)... ... , ... The Utah Department of Health (UDOH) has contracted with STACS DNA ... the state. The system will be deployed to all birthing hospitals to reduce ... in Salt Lake City. This supports UDOH’s goals of saving lives and improving babies’ ...
Breaking Biology News(10 mins):